HopeStage
Back to all studies
WithdrawnNCT06213298

Effect of Kava on Anxiety and Stress in Cancer Survivors

Medication studyAges 18+United States
The study in practice

Understand this study

Who could participate?

Listed age limits: from 18 years.

Listed locations
MinneapolisSee all locations and recruitment
Study phase
Early phase 1An early first-in-human or very early safety study, usually focused on how a treatment behaves in the body.

Get this study by email

HopeStage may email me about this study.
Loading the security check...

What to know before participating

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Things to check before joining

Study start dateStarted: June 20, 2024
Recruitment status
Withdrawn
Enrollment listed in the registry
0
Sponsor
Masonic Cancer Center, University of Minnesota
Sponsor type
University
Study type
Drug
Intervention type
Dietary supplement, Drug
Study phase
Early Phase 1An early first-in-human or very early safety study, usually focused on how a treatment behaves in the body.
Locations
United States
Age range
Over 18 Years
Official registry ID
NCT06213298
Official title
Show the full official title

Effect of Kava on Anxiety and Stress in Cancer Survivors

Recruitment & locations

Withdrawn

Minneapolis

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is Masonic Cancer Center, University of Minnesota, a university.

Does this study involve medication?

Yes. The study involves medication, including Kava.

Who can participate?

Listed age limits: from 18 years.

Is this study still recruiting?

The registry lists this study as withdrawn.

Want to explore more studies?

Explore studies